The American Society of Anesthesiologists (ASA) is pressing the Centers for Medicare & Medicaid Services (CMS) to reverse proposed policy changes that would eliminate Medicare coverage for peripheral nerve blocks used in the treatment of chronic pain. The ASA applauded a bipartisan group of 25 members of Congress who voiced their opposition to the proposed changes in a letter to CMS, according to a news release issued March 20.
The proposed coverage restrictions stem from decisions made by five regional Medicare Administrative Contractors (MACs), the lawmakers warned CMS. Restricting access to non-opioid pain treatments like peripheral nerve blocks, they argued, could inadvertently lead to increased opioid prescriptions and potential misuse among Medicare beneficiaries.
The ASA has joined forces with the Pain Medicine Coalition and other pain management organizations to advocate for the continued coverage of these procedures. Representatives from these groups have directly engaged with Medicare contractors, submitting formal written comments that highlight the clinical evidence supporting the effectiveness of peripheral nerve blocks and the benefits they provide to patients, the ASA stated.
According to reporting from Radiology Business, the proposed changes specifically target image-guided pain procedures. Similarly, Healio reported that Medicare contractors are considering restricting coverage of peripheral nerve block procedures. Statnews.com detailed how the proposed changes in Medicare coverage threaten access to procedures used to treat pain.
The ASA is urging CMS to withdraw the proposals, asserting that they would negatively impact patient care and undermine national efforts to reduce reliance on opioid medications. The organization maintains that peripheral nerve blocks offer a valuable, non-opioid alternative for managing chronic pain, and limiting access to these treatments would be counterproductive to public health goals.
The debate over Medicare coverage for pain management procedures comes as the healthcare industry continues to seek alternatives to opioid-based pain relief. The ASA’s advocacy reflects a broader effort to promote multimodal pain management strategies that prioritize non-pharmacological and non-opioid interventions.
Surgeons, orthopedic leaders, and ASC executives are scheduled to convene at the Becker’s 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference in Chicago, June 18–20, to discuss minimally invasive techniques and ASC growth strategies.
Leave a Reply